The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to finish the week strongly and is up 0.9% to 5,788 points in early afternoon trade.
Four shares which are having an even stronger finish to the week are listed below. Here's why they are ending the week with a bang:
The Fletcher Building Limited (Australia) (ASX: FBU) share price is up 3% to $7.36 today thanks to a positive research note out of Deutsche Bank. Its analysts reiterated their buy rating on its shares after its research showed that New Zealand construction demand remains strong. If this proves to be the case then Fletcher Building could prove to be great value for money in my opinion.
The Orocobre Limited (ASX: ORE) share price is up 5.5% to $3.85 despite there being no news out of the lithium miner. A presentation released by rival Galaxy Resources Limited (ASX: GXY) today could be behind the gain. Galaxy's presentation shows that the lithium-ion battery application mix is transitioning from being dominated by consumer electrics to new energy vehicle applications. It believes the strong demand will support the high prices lithium is currently commanding.
The OBJ Limited (ASX: OBJ) share price is up almost 8% to 5.6 cents after the drug delivery technology company provided a trading update. According to the release OBJ received $127,400 of royalties from its skincare technology licensee in the March quarter. Furthermore, the company has received its first standstill and royalty fees of approximately $169,000 for the second technology licensed to global giant Procter & Gamble.
The Zelda Therapeutics Ltd (ASX: ZLD) share price has rocketed 32% to 7.4 cents after the medicinal cannabis company reported positive results from its ongoing pre-clinical research into the use of cannabinoids as anti-cancer agents. A series of in vitro studies have confirmed that both THC-rich and CBD-rich oils have had a statistically significant anti-cancer effect across a range of different breast cancer cell lines.
